Instalab
Ozempic · semaglutide · once-weekly injection

Lower A1C. Cut CV events in diabetes.

The once-weekly GLP-1 for type 2 diabetes. Ozempic® (semaglutide) is approved for glycemic control and reducing cardiovascular events in diabetics with established CVD. Prescription, titration, and physician follow-up included.

1.5–2.0%Typical A1C reduction
26%Reduction in MACE (SUSTAIN-6)
Once weeklyPre-filled pen injection
Ozempic Prescription Review
Ozempic · 0.25 → 2.0mg · once weekly · for type 2 diabetes
Licensed US physician review
12,000+ patients treated
Available in all 50 states
Ongoing titration and follow-up
How it works

From questionnaire to first injection.

No clinic visits. A licensed physician reviews your case, picks the right starting dose, and manages each titration step. We handle refills and follow-up.

Step 1

2-minute questionnaire

Tell us about your A1C, diabetes history, prior diabetes medications, and cardiovascular history.

Step 2

Physician review

A licensed physician confirms Ozempic is appropriate (FDA-approved for type 2 diabetes), screens for contraindications, and writes your starting prescription. Usually within 1 business day.

Step 3

Cost check and dispensing

We verify insurance and file prior authorization. If self-pay makes more sense, we shop pharmacy options.

Step 4

Titration and A1C recheck

Start at 0.25mg weekly for 4 weeks (a titration-only dose). Step up to 0.5mg, then 1mg, then 2mg every 4 weeks as tolerated. Recheck A1C at 3 months.

Pricing

What you'll actually pay.

Two line items: Instalab Membership and the Ozempic medication itself, dispensed by your pharmacy.

Instalab Membership

Physician oversight, titration management, A1C and metabolic follow-up, ongoing care

$—/mo

Ozempic (semaglutide injection)

Brand-name only, dispensed by your pharmacy

Cash price$349–499/monthTypical brand cash price
With insurance$25–100/monthTypical copay, if covered

Why pay a membership fee? Ozempic needs a physician who manages titration, side effects, and metabolic monitoring across 4 monthly dose steps. Membership covers the visits, prior authorization, and refill paperwork. Insurance coverage for type 2 diabetes is generally strong; cash price is high because no generic exists. You pick up the prescription at your pharmacy and pay them directly.

Will my insurance cover Ozempic?

Most commercial and Medicare plans cover Ozempic for type 2 diabetes, often with prior authorization confirming the diabetes diagnosis. Copays are typically $25 to $100 per month with coverage. We file the prior authorization. Ozempic is brand-only; if insurance does not cover, cash price is high (typically $900 to $1,000 per month).

Why membership

Ozempic works. Titration and follow-up take ongoing care.

It needs a physician who manages dose increases, side effects, and metabolic monitoring across the titration steps. Here's how our team handles that for you.

  1. Week 1Day 1–5

    Physician evaluation and prescription

    A licensed physician reviews your diabetes history, A1C, and CV risk, then writes your starting prescription at 0.25mg weekly. We verify insurance and file prior authorization in parallel.

  2. Week 2

    First injection at home

    Your Ozempic pen ships from the pharmacy. We walk you through self-injection and check in after your first dose.

  3. Week 4+

    Monthly titration

    Step up to 0.5mg, then 1mg, then 2mg every 4 weeks if tolerated. We coordinate each refill with the new dose so you never run short.

  4. Month 3+

    A1C recheck and ongoing care

    Recheck A1C at month 3. Most patients drop 1.5 to 2.0%. Your physician tracks A1C, weight, and labs over time and adjusts as needed.

Without membership

Schedule a PCP or endocrinology visit. Wait months. Chase prior auth and refills yourself. Manage side effects between appointments.

With Instalab

2-minute questionnaire. Physician review within 1 business day. Insurance and titration handled. Refills and side-effect check-ins built in.

About the medication

One injection a week.

Ozempic is a once-weekly subcutaneous injection from a pre-filled pen. Same day each week. Stomach, thigh, or upper arm. Most patients build the habit in a few weeks.

  • Pre-filled pen, once weeklyEach pen contains multiple doses. Dial your prescribed dose, press to skin, hold. A pen typically lasts about 4 weeks.
  • Pick a weekday, any time of dayTake it the same day each week. Day-of-week consistency matters more than time-of-day.
  • Monthly titrationStart at 0.25mg, step up monthly. The 0.25mg dose is for titration only, not glucose control.
  • Ongoing physician supportYour care team is a message away for nausea, dose timing, and metabolic monitoring.
Why Ozempic

A1C, weight, and cardiovascular events — all in one molecule.

Ozempic is the original brand of semaglutide. It activates the GLP-1 receptor: slows gastric emptying, lowers appetite, and stimulates insulin release when glucose is high. The SUSTAIN trials established its A1C, weight, and cardiovascular effects. The SUSTAIN-6 CV outcomes trial in particular drove the FDA approval for cardiovascular risk reduction in adults with diabetes and established CVD.

  • 1.5 to 2.0% A1C reductionAcross SUSTAIN trials, Ozempic produced an average A1C drop of 1.5 to 2.0% at the 1mg and 2mg doses, with most patients reaching guideline targets.
  • 26% reduction in MACE (SUSTAIN-6)SUSTAIN-6 randomized 3,297 adults with type 2 diabetes and high CV risk to semaglutide or placebo. Semaglutide reduced the composite of CV death, MI, and stroke by 26%, driving the FDA approval for cardiovascular risk reduction.
  • Substantial weight loss as a side benefitOzempic typically produces 5 to 10% body weight loss in patients with type 2 diabetes, though it is not FDA-approved as a weight-loss medication. For weight loss specifically, semaglutide is approved as Wegovy at higher doses.

The SUSTAIN-6 trial

Published in NEJM in 2016, SUSTAIN-6 randomized 3,297 adults with type 2 diabetes at high CV risk to semaglutide (0.5 or 1mg weekly) or placebo. Over a median 2.1 years, semaglutide reduced the primary composite of cardiovascular death, MI, and stroke by 26%. This drove the FDA approval for CV risk reduction in adults with diabetes and established cardiovascular disease.

3,297
Patients with T2D randomized
26%
MACE reduction
2.1 yrs
Median follow-up

Ozempic is a prescription medicine. Important safety information applies. The most common side effects are gastrointestinal. There is a boxed warning for thyroid C-cell tumors, based on rodent studies.

Ready when you are

Lower A1C. Reduce CV risk in diabetes.

Answer the questionnaire. A physician reviews your case and, if Ozempic is appropriate, prescribes it. We handle titration, refills, and follow-up.

No commitment to treatment. Ozempic is for type 2 diabetes.